Neurogene Inc.
NGNE
$20.00
$0.763.95%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 4.83% | 2.79% | -16.06% | 3.48% | -9.33% |
| Total Depreciation and Amortization | 1.17% | 0.66% | -4.51% | -1.12% | -1.22% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -11.61% | -13.35% | 19.33% | 64.93% | -51.79% |
| Change in Net Operating Assets | -215.46% | 71.64% | -57.81% | -134.96% | 391.58% |
| Cash from Operations | -0.24% | 6.32% | -18.74% | -12.41% | 2.07% |
| Capital Expenditure | 14.19% | 81.03% | -572.41% | 30.54% | 63.70% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 191.09% | 117.16% | 56.81% | -255.92% | -24.38% |
| Cash from Investing | 195.17% | 116.54% | 56.10% | -254.26% | -22.66% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 7.14% | 6.67% | -15.38% | -8.33% | 25.00% |
| Issuance of Common Stock | 14,442.65% | 257.89% | -99.99% | 132,821.68% | -65.54% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 17,881.48% | 1,250.00% | -100.00% | 144,987.79% | -67.17% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 201.96% | 81.83% | -194.08% | 257.56% | -13.53% |